End Nears for Purdue’s Opioid Woes With Justice Department Deal

Purdue Pharma is poised to wrap up all liability for its role in the opioid crisis in a matter of weeks after its $8.3 billion settlement with the Justice Department cleared the way to resolve outstanding bankruptcy claims.

Purdue’s settlement with the DOJ was the critical domino that needed to fall before roughly 3,000 cities and counties that are claimants in the bankruptcy could get their slice of the pie, said Harry Nelson, co-founder of Nelson Hardiman, a Los Angeles-based health-care law firm.

“I would be surprised if we don’t have a Purdue resolution before Thanksgiving,” he said.

“I have ...